Literature DB >> 18723162

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.

Davangere P Devanand1, Xinhua Liu, Matthias H Tabert, Gnanavalli Pradhaban, Katrina Cuasay, Karen Bell, Mony J de Leon, Richard L Doty, Yaakov Stern, Gregory H Pelton.   

Abstract

BACKGROUND: The utility of combining early markers to predict conversion from mild cognitive impairment (MCI) to Alzheimer's Disease (AD) remains uncertain.
METHODS: Included in the study were 148 outpatients with MCI, broadly defined, followed at 6-month intervals. Hypothesized baseline predictors for follow-up conversion to AD (entire sample: 39/148 converters) were cognitive test performance, informant report of functional impairment, apolipoprotein E genotype, olfactory identification deficit, and magnetic resonance imaging (MRI) hippocampal and entorhinal cortex volumes.
RESULTS: In the 3-year follow-up patient sample (33/126 converters), five of eight hypothesized predictors were selected by backward and stepwise logistic regression: Pfeffer Functional Activities Questionnaire (FAQ; informant report of functioning), University of Pennsylvania Smell Identification Test (UPSIT; olfactory identification), Selective Reminding Test (SRT) immediate recall (verbal memory), MRI hippocampal volume, and MRI entorhinal cortex volume. For 10% false positives (90% specificity), this five-predictor combination showed 85.2% sensitivity, combining age and Mini-Mental State Examination (MMSE) showed 39.4% sensitivity; combining age, MMSE, and the three clinical predictors (SRT immediate recall, FAQ, and UPSIT) showed 81.3% sensitivity. Area under ROC curve was greater for the five-predictor combination (.948) than age plus MMSE (.821; p = .0009) and remained high in subsamples with MMSE > or = 27/30 and amnestic MCI.
CONCLUSIONS: The five-predictor combination strongly predicted conversion to AD and was markedly superior to combining age and MMSE. Combining the clinically administered measures also led to strong predictive accuracy. If independently replicated, the findings have potential utility for early detection of AD.

Entities:  

Mesh:

Year:  2008        PMID: 18723162      PMCID: PMC2613777          DOI: 10.1016/j.biopsych.2008.06.020

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  40 in total

1.  Hippocampal formation glucose metabolism and volume losses in MCI and AD.

Authors:  S De Santi; M J de Leon; H Rusinek; A Convit; C Y Tarshish; A Roche; W H Tsui; E Kandil; M Boppana; K Daisley; G J Wang; D Schlyer; J Fowler
Journal:  Neurobiol Aging       Date:  2001 Jul-Aug       Impact factor: 4.673

2.  Functional deficits in patients with mild cognitive impairment: prediction of AD.

Authors:  M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

3.  Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status.

Authors:  A B Graves; J D Bowen; L Rajaram; W C McCormick; S M McCurry; G D Schellenberg; E B Larson
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

4.  Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.

Authors:  D H Silverman; G W Small; C Y Chang; C S Lu; M A Kung De Aburto; W Chen; J Czernin; S I Rapoport; P Pietrini; G E Alexander; M B Schapiro; W J Jagust; J M Hoffman; K A Welsh-Bohmer; A Alavi; C M Clark; E Salmon; M J de Leon; R Mielke; J L Cummings; A P Kowell; S S Gambhir; C K Hoh; M E Phelps
Journal:  JAMA       Date:  2001-11-07       Impact factor: 56.272

5.  Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study.

Authors:  Suzanne L Tyas; Juan Carlos Salazar; David A Snowdon; Mark F Desrosiers; Kathryn P Riley; Marta S Mendiondo; Richard J Kryscio
Journal:  Am J Epidemiol       Date:  2007-04-12       Impact factor: 4.897

6.  Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

Authors:  D P Devanand; K S Michaels-Marston; X Liu; G H Pelton; M Padilla; K Marder; K Bell; Y Stern; R Mayeux
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

7.  Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.

Authors:  A S Fleisher; B B Sowell; C Taylor; A C Gamst; R C Petersen; L J Thal
Journal:  Neurology       Date:  2007-02-07       Impact factor: 9.910

8.  Neuropsychological measures in normal individuals that predict subsequent cognitive decline.

Authors:  Deborah Blacker; Hang Lee; Alona Muzikansky; Emily C Martin; Rudolph Tanzi; John J McArdle; Mark Moss; Marilyn Albert
Journal:  Arch Neurol       Date:  2007-06

9.  Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.

Authors:  Sandip Ray; Markus Britschgi; Charles Herbert; Yoshiko Takeda-Uchimura; Adam Boxer; Kaj Blennow; Leah F Friedman; Douglas R Galasko; Marek Jutel; Anna Karydas; Jeffrey A Kaye; Jerzy Leszek; Bruce L Miller; Lennart Minthon; Joseph F Quinn; Gil D Rabinovici; William H Robinson; Marwan N Sabbagh; Yuen T So; D Larry Sparks; Massimo Tabaton; Jared Tinklenberg; Jerome A Yesavage; Robert Tibshirani; Tony Wyss-Coray
Journal:  Nat Med       Date:  2007-10-14       Impact factor: 53.440

10.  Magnetic resonance imaging predictors of cognition in mild cognitive impairment.

Authors:  Laura A van de Pol; Esther S C Korf; Wiesje M van der Flier; H Robert Brashear; Nick C Fox; Frederik Barkhof; Philip Scheltens
Journal:  Arch Neurol       Date:  2007-07
View more
  125 in total

1.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Georgina Vinyes-Junqué; Ana Espinosa; Sergi Valero; Isabel Hernández; Isabel Roca; Agustín Ruíz; Maitée Rosende-Roca; Ana Mauleón; James T Becker; Joan Castell-Conesa; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment.

Authors:  Richard P Kline; Elizabeth Pirraglia; Hao Cheng; Susan De Santi; Yi Li; Michael Haile; Mony J de Leon; Alex Bekker
Journal:  Anesthesiology       Date:  2012-03       Impact factor: 7.892

3.  Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?

Authors:  Daniel W Wesson; Donald A Wilson; Ralph A Nixon
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

4.  Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease.

Authors:  Wen Li; James D Howard; Jay A Gottfried
Journal:  Brain       Date:  2010-08-19       Impact factor: 13.501

5.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Ana Espinosa; Sergi Valero; Isabel Hernández; Agustín Ruíz; James T Becker; Maitée Rosende-Roca; Ana Mauleón; Oscar Sotolongo; Joan Castell-Conesa; Isabel Roca; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.

Authors:  D P Devanand; Ravi Bansal; Jun Liu; Xuejun Hao; Gnanavalli Pradhaban; Bradley S Peterson
Journal:  Neuroimage       Date:  2012-01-25       Impact factor: 6.556

7.  Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up.

Authors:  Shanshan Li; Ozioma Okonkwo; Marilyn Albert; Mei-Cheng Wang
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

8.  Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.

Authors:  Alefiya Dhilla Albers; Josephine Asafu-Adjei; Mary K Delaney; Kathleen E Kelly; Teresa Gomez-Isla; Deborah Blacker; Keith A Johnson; Reisa A Sperling; Bradley T Hyman; Rebecca A Betensky; Lloyd Hastings; Mark W Albers
Journal:  Ann Neurol       Date:  2016-11-23       Impact factor: 10.422

Review 9.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

10.  Nitrogen dioxide pollution exposure is associated with olfactory dysfunction in older U.S. adults.

Authors:  Dara R Adams; Gaurav S Ajmani; Vivian C Pun; Kristen E Wroblewski; David W Kern; L Philip Schumm; Martha K McClintock; Helen H Suh; Jayant M Pinto
Journal:  Int Forum Allergy Rhinol       Date:  2016-09-13       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.